doi: Nauck, M.A., Quast, D.R., Jakob Wefers and Meier, J.J
44% of firms with 1,000 to 4,999 workers, and 59% of firms with 5,000 or more workers say that the use of these medications for weight loss was higher than expected
Only affordable GLP-1s and Behavior Change will bend this curve
Screening for depression, anxiety, and eating disorders should occur regularly, as these conditions may contribute to weight regain and affect treatment response
Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease
Weeks 5 to 8: significant progress This phase brings substantial improvement for most users